臨床検査薬市場：タイプ別、消耗品別、検体別、用途別、エンドユーザー別-2025-2030年の世界予測

臨床検査薬市場は、2024年には1,263億3,000万米ドルとなり、2025年には1,355億9,000万米ドルに成長し、CAGRは7.45%、2030年には1,945億米ドルに達すると予測されています。

臨床検査のダイナミックな世界では、急速な技術革新と進化する技術が絶えず状況を塗り替えてきました。この概説では、臨床検査における現在の動向、新たな発見、新しい調査手法の影響について掘り下げます。過去数年間、この分野は、早期診断、個別化医療、検査工程の効率化への関心の高まりにより、かつてない成長を遂げてきました。

テクノロジーと医学が交差することで、検査室はより正確で迅速な検査を実施できるようになりました。検査室は現在、高度な分析技術、自動化、デジタルヘルス・ソリューションを活用し、より迅速に結果を提供し、より良い患者ケアを推進しています。これらの技術革新は、疾患の早期発見、慢性疾患のモニタリング、個々の遺伝子プロファイルに合わせた治療プロトコルの調整など、拡大する臨床課題の解決に役立っています。

本レポートを読み進めていくと、テクノロジーと調査への継続的な投資が、検査室のワークフローを合理化するだけでなく、疾病のパターンや集団の健康状態をより広く理解することにも貢献していることがわかる。世界中のヘルスケアシステムにおいて臨床検査室が不可欠な役割を担っていることは、この重要な分野における継続的な進化と戦略的計画の必要性を強調しています。

臨床検査薬市場の変革

近年、臨床検査分野は大きく変化しています。最先端の診断ツール、革新的な技術、そしてますます洗練された手法により、検査パラメータと結果が再定義されました。検査室は、リアルタイムの意思決定を可能にする自動化されたワークフローと統合されたデータ管理システムを採用しています。このような変化により、検査はより正確で迅速なものとなり、さまざまな臨床場面でますます利用しやすくなっています。

効率化の推進により、手順の標準化が進み、コンプライアンス・プロトコルの進化により、検査室は科学的発見の限界を押し広げながら、規制当局の期待に遅れないようにしています。デジタルヘルスソリューションの統合は、臨床医間のシームレスなデータ共有を促進し、診断精度と患者管理を強化しています。さらに、人工知能と機械学習が従来の検査室業務に融合することで、予測的洞察が可能となり、重大な健康問題に発展する前に異常を確実に検出することができます。

この重大な変化の瞬間において、利害関係者は単に市場の圧力に反応するだけでなく、革新的な研究、最先端技術、診断ベンチマークを再定義する共同研究に投資することにより、積極的に未来を形成しています。

臨床検査室検査における主要なセグメンテーション洞察

臨床検査市場は、様々なセグメンテーションによって顕著な多様性を示しています。種類別に評価すると、市場は生化学検査、遺伝子検査、免疫学・血清学検査、微生物学検査、病理学検査などの横断的なセグメントにまたがっており、それぞれが臨床診断に独自に貢献しています。消耗品に焦点を当てた分析では、厳格な検査基準を維持するために不可欠なアッセイキット、検査機器、個人用保護具、試薬、検体採取装置の重要性が明らかになりました。

セグメンテーションはさらに、血液、唾液、便、尿などの重要な検査媒体を含む検体の種類にまで及んでおり、これらの検体は幅広い疾患の検出とモニタリングに不可欠です。アプリケーションの領域では、市場は自己免疫疾患、心血管疾患、遺伝性疾患、感染症、腫瘍性疾患などの検査項目によって層別化されており、これらの診断薬の広範な臨床的有用性を反映しています。最後に、市場は診断研究所、病院、研究機関などのエンドユーザー別に多様化されています。このような多面的なセグメンテーションの枠組みは、市場の複雑性を強調するだけでなく、技術強化や戦略的拡大の機会を豊富に秘めていることを示唆しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患の有病率が増加
    • 発展途上地域におけるヘルスケアインフラの拡大
    • 専門的な臨床検査を必要とする個別化医療への意識と採用の高まり
  • 抑制要因
    • 高い運用コストと複雑な物流
  • 機会
    • AIとビッグデータ分析と臨床検査の統合
    • 臨床検査薬の精度と効率性を高める技術の進歩
  • 課題
    • 新興のデジタルヘルスソリューションや家庭用検査キットとの厳しい競合
• 市場セグメンテーション分析
  • タイプ：非侵襲性のため集団スクリーニングにおける生化学検査の重要性が高まっている
  • エンドユーザー：病院における臨床検査薬の利用拡大
  • 適応症：予測分析と精密医療の重要性の高まりに伴う遺伝性疾患検査の進歩
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 臨床検査薬市場：タイプ別

• 生化学検査
• 遺伝子検査
• 免疫学/血清学検査
• 微生物学的検査
• 病理検査

第7章 臨床検査薬市場消耗品

• アッセイキット
• 実験装置
• 個人用保護具
• 試薬
• サンプル収集装置

第8章 臨床検査薬市場標本別

• 血
• 唾液
• スツール
• 尿

第9章 臨床検査薬市場：用途別

• 自己免疫疾患
• 心血管疾患
• 遺伝性疾患
• 感染症
• 腫瘍性疾患

第10章 臨床検査薬市場：エンドユーザー別

• 診断検査室
• 病院
• 調査機関

第11章 南北アメリカの臨床検査薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の臨床検査薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの臨床検査薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Accu Reference Medical Lab, LLC
• Apollo Health and Lifestyle Limited
• Arup Laboratories Inc.
• Aster Clinical Lab LLP
• Bioscientia Healthcare GmbH
• Biosino Bio-technology and Science Inc.
• Charles River Laboratories, Inc
• Cinven Ltd.
• Clinical Reference Laboratory, Inc.
• DaVita Inc. by UnitedHealth Group Inc.
• Dr Lal PathLabs Pvt. Ltd
• Eurofins Scientific SE
• Fresenius Medical Care AG & Co KGaA
• Laboratory Corporation of America Holdings
• Merck KgaA
• Metropolis Health Products Retail Pvt Ltd.
• NeoGenomics, Inc.
• Novartis International AG
• OPKO Health, Inc.
• PerkinElmer, Inc.
• Qiagen .N.V.
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sonic Healthcare Limited
• SYNLAB Group
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. CLINICAL LABORATORY TESTS MARKET MULTI-CURRENCY
• FIGURE 2. CLINICAL LABORATORY TESTS MARKET MULTI-LANGUAGE
• FIGURE 3. CLINICAL LABORATORY TESTS MARKET RESEARCH PROCESS
• FIGURE 4. CLINICAL LABORATORY TESTS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. CLINICAL LABORATORY TESTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. CLINICAL LABORATORY TESTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL LABORATORY TESTS MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY IMMUNOLOGY/SEROLOGY TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY MICROBIOLOGY TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PATHOLOGY TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY SAMPLE COLLECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY STOOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ONCOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 170. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 171. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 190. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 191. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 195. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 196. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 244. CLINICAL LABORATORY TESTS MARKET, FPNV POSITIONING MATRIX, 2024

The Clinical Laboratory Tests Market was valued at USD 126.33 billion in 2024 and is projected to grow to USD 135.59 billion in 2025, with a CAGR of 7.45%, reaching USD 194.50 billion by 2030.

In the dynamic world of clinical laboratory testing, rapid innovation and evolving technologies have continuously reshaped the landscape. This overview dives into the current trends, emerging discoveries, and the impact of new methodologies in clinical testing. Over the past several years, the field has experienced unprecedented growth driven by an increased focus on early diagnostics, personalized medicine, and efficiency in laboratory processes.

The intersection of technology and medical science has enabled laboratories to conduct tests with greater precision and quick turnaround times. Laboratories now leverage advanced analytical techniques, automation, and digital health solutions to deliver results faster and drive better patient care. These innovations help address an expanding array of clinical challenges, including the early detection of diseases, monitoring of chronic conditions, and tailoring treatment protocols to individual genetic profiles.

As we explore this report, it is clear that continued investment in technology and research not only streamlines laboratory workflows, but also contributes to a broader understanding of disease patterns and population health. The indispensable role of clinical laboratories in healthcare systems worldwide underscores the need for ongoing evolution and strategic planning in this critical field.

Transformative Shifts in the Clinical Laboratory Testing Landscape

Recent years have witnessed transformative shifts in the field of clinical laboratory testing. Cutting-edge diagnostic tools, innovative technologies, and increasingly sophisticated methodologies have redefined testing parameters and outcomes. Laboratories are adopting automated workflows and integrated data management systems that enable real-time decision-making. These changes have made testing more accurate, faster, and increasingly accessible across varied clinical scenarios.

The drive for efficiency has led to improved standardization of procedures; evolving compliance protocols have ensured that laboratories keep pace with regulatory expectations while pushing the boundaries of scientific discovery. The integration of digital health solutions has facilitated seamless data sharing among clinicians, enhancing diagnostic precision and patient management. Furthermore, the convergence of artificial intelligence and machine learning with traditional laboratory practices offers predictive insights, ensuring that anomalies are detected before they escalate into serious health issues.

In this moment of significant change, stakeholders are not merely reacting to market pressures, but actively shaping the future by investing in innovative research, state-of-the-art technology, and collaborations that redefine diagnostic benchmarks.

Key Segmentation Insights in Clinical Laboratory Testing

The clinical laboratory testing market exhibits a remarkable diversity driven by various dimensions of segmentation. When evaluated by type, the market spans cross-sectional segments such as biochemical tests, genetic tests, immunology and serology tests, microbiology tests, and pathology tests, each contributing uniquely to clinical diagnostics. An analysis focused on consumables reveals the importance of assay kits, laboratory equipment, personal protective equipment, reagents, and sample collection devices, all of which are vital for maintaining rigorous testing standards.

The segmentation further extends to specimen types with critical testing mediums including blood, saliva, stool, and urine, which are essential for detecting and monitoring a wide array of conditions. In the realm of application, the market is stratified by testing grounds such as autoimmune diseases, cardiovascular diseases, genetic disorders, infectious diseases, and oncological diseases, reflecting the broad clinical utility of these diagnostics. Lastly, the market is diversified by end users, which include diagnostic laboratories, hospitals, and research institutes. This multifaceted segmentation framework not only underscores the complexity of the market but also points to a rich canvas of opportunities for technology enhancement and strategic expansion.

Based on Type, market is studied across Biochemical Tests, Genetic Tests, Immunology/Serology Tests, Microbiology Tests, and Pathology Tests.

Based on Consumables, market is studied across Assay Kits, Laboratory Equipment, Personal Protective Equipment, Reagents, and Sample Collection Devices.

Based on Specimen, market is studied across Blood, Saliva, Stool, and Urine.

Based on Application, market is studied across Autoimmune Diseases, Cardiovascular Diseases, Genetic Disorders, Infectious Diseases, and Oncological Diseases.

Based on End User, market is studied across Diagnostic Laboratories, Hospitals, and Research Institutes.

Key Regional Insights in Laboratory Testing Markets

A thorough assessment of the clinical laboratory testing market reveals significant regional dynamics that influence market expansion and strategy. In the Americas, innovative research initiatives and robust healthcare infrastructures have created an environment where advanced diagnostic technologies are rapidly adopted and integrated into standard practice. The combination of technological progression and a strong emphasis on preventive care has driven market growth, setting high benchmarks for accuracy in diagnostics.

Across Europe, the Middle East, and Africa, a confluence of traditional practices and modern laboratory techniques is distinctly visible. Investment in healthcare modernization and the integration of digital technologies have laid the groundwork for a diverse yet cohesive market that prioritizes quality and accessibility. Regulatory frameworks and public-private partnerships in these regions have accelerated the adoption of best practices, ensuring that testing reliability and efficiency remain paramount.

Moving towards the Asia-Pacific region, rapid economic growth, rising healthcare awareness, and government-led initiatives to expand laboratory networks have collectively fueled the market's expansion. Innovations in diagnostic technologies and a proactive approach to healthcare reforms have catalyzed market development and contributed to a broader spectrum of testing capabilities. Overall, the interplay between regional regulatory landscapes and local market dynamics creates a robust and competitive environment that continues to drive growth globally.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation in Clinical Laboratory Testing

The clinical laboratory testing industry is characterized by the active involvement of a host of influential companies that are steadfast in their pursuit of innovation. Market leaders such as Abbott Laboratories, Accu Reference Medical Lab, LLC, Apollo Health and Lifestyle Limited, and Arup Laboratories Inc. stand at the forefront by continually introducing transformative diagnostic solutions. These enterprises, along with Aster Clinical Lab LLP, Bioscientia Healthcare GmbH, and Biosino Bio-technology and Science Inc., play pivotal roles in advancing clinical diagnostics through strategic investments and robust research initiatives.

Prominent firms such as Charles River Laboratories, Inc, Cinven Ltd., Clinical Reference Laboratory, Inc., and DaVita Inc. by UnitedHealth Group Inc. significantly impact the diagnostic arena by integrating next-generation technologies into existing frameworks. Other key players including Dr Lal PathLabs Pvt. Ltd, Eurofins Scientific SE, Fresenius Medical Care AG & Co KGaA, and Laboratory Corporation of America Holdings contribute to a vibrant ecosystem where technological progression is seamlessly paired with patient-centric approaches. This momentum is further bolstered by the efforts of Merck KgaA, Metropolis Health Products Retail Pvt Ltd., NeoGenomics, Inc., Novartis International AG, OPKO Health, Inc., PerkinElmer, Inc., Qiagen .N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Sonic Healthcare Limited, SYNLAB Group, and Thermo Fisher Scientific Inc. Their collective drive towards innovation enhances clinical accuracy and efficiency, ensuring that the laboratory testing space remains highly competitive and continuously evolving.

The report delves into recent significant developments in the Clinical Laboratory Tests Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accu Reference Medical Lab, LLC, Apollo Health and Lifestyle Limited, Arup Laboratories Inc., Aster Clinical Lab LLP, Bioscientia Healthcare GmbH, Biosino Bio-technology and Science Inc., Charles River Laboratories, Inc, Cinven Ltd., Clinical Reference Laboratory, Inc., DaVita Inc. by UnitedHealth Group Inc., Dr Lal PathLabs Pvt. Ltd, Eurofins Scientific SE, Fresenius Medical Care AG & Co KGaA, Laboratory Corporation of America Holdings, Merck KgaA, Metropolis Health Products Retail Pvt Ltd., NeoGenomics, Inc., Novartis International AG, OPKO Health, Inc., PerkinElmer, Inc., Qiagen .N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Sonic Healthcare Limited, SYNLAB Group, and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders to Drive Market Growth

Industry leaders must focus on a multilayered approach to navigate the intricacies of the ever-evolving clinical laboratory testing landscape. The first step is investing significantly in technology innovations that decrease turnaround times while enhancing diagnostic accuracy. Leaders should explore the deployment of state-of-the-art automation systems, digital data management platforms, and advanced diagnostic tools that integrate artificial intelligence with conventional technologies. This form of investment not only streamlines laboratory workflows but also increases overall efficiency and reliability.

Another critical recommendation is to foster collaborations with research institutes, technology companies, and regulatory bodies. Such alliances can create synergies that drive exploratory research and facilitate rapid translation from laboratory findings to clinical applications. It is important to balance short-term gains with long-term strategic planning, ensuring that innovation remains at the forefront of operational goals.

Moreover, continuous professional development and training for laboratory personnel are essential. Equipping teams with the latest knowledge and techniques will empower them to confidently manage sophisticated testing methodologies. Emphasis should be placed on quality control measures and compliance with international standards, ultimately ensuring that market shifts are met with agile responses and sustainable growth. Leaders who adopt these actionable recommendations will not only excel in operational efficiency but also prepare their organizations to meet future challenges with resilience and strategic foresight.

Conclusion: Summarizing the Critical Insights in Laboratory Testing

The intricate landscape of clinical laboratory testing, as detailed above, reflects a multifaceted industry where innovation and technological advancements are pivotal. From the groundbreaking transition in diagnostic measures and the strategic segmentation across test types, consumables, specimens, and clinical applications to the regional dynamics that underscore market expansion, every facet of this sector plays a decisive role in shaping the future of healthcare diagnostics.

Emphasizing the market's robust innovation when viewed through the prism of influential companies and dependable regional markets, it is clear that continuous reinvestment in research and technology is both indispensable and rewarding. The convergence of automation, data analytics, and digital health is forming a backbone of reliability and efficiency that supports improved patient outcomes and operational excellence.

In the context of a rapidly evolving healthcare landscape, the insights provided not only form a compass for understanding current trends, but also serve as a guide for future explorations and investments. The combined weight of technological advancement, streamlined segmentation strategies, and proactive regional initiatives ensures that the industry remains agile and responsive in the face of emerging global challenges.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases worldwide
    • 5.1.1.2. Growing healthcare infrastructure in developing regions
    • 5.1.1.3. Rising awareness and adoption of personalized medicine requiring specialized laboratory evaluations
  • 5.1.2. Restraints
    • 5.1.2.1. High operational costs and complex logistics
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of AI and big data analytics with clinical laboratory testing
    • 5.1.3.2. Advancements in technology enhancing accuracy and efficiency of clinical laboratory tests
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent competition from emerging digital health solutions and home testing kits
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Rising significance of biochemical tests for mass screening owing to their non-invasive nature
  • 5.2.2. End User: Expanding utilization of clinical laboratory tests among hospitals
  • 5.2.3. Indication: Advancements in the genetic disorder testing with growing significance of predictive analytics and precision medicine
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Laboratory Tests Market, by Type

• 6.1. Introduction
• 6.2. Biochemical Tests
• 6.3. Genetic Tests
• 6.4. Immunology/Serology Tests
• 6.5. Microbiology Tests
• 6.6. Pathology Tests

7. Clinical Laboratory Tests Market, by Consumables

• 7.1. Introduction
• 7.2. Assay Kits
• 7.3. Laboratory Equipment
• 7.4. Personal Protective Equipment
• 7.5. Reagents
• 7.6. Sample Collection Devices

8. Clinical Laboratory Tests Market, by Specimen

• 8.1. Introduction
• 8.2. Blood
• 8.3. Saliva
• 8.4. Stool
• 8.5. Urine

9. Clinical Laboratory Tests Market, by Application

• 9.1. Introduction
• 9.2. Autoimmune Diseases
• 9.3. Cardiovascular Diseases
• 9.4. Genetic Disorders
• 9.5. Infectious Diseases
• 9.6. Oncological Diseases

10. Clinical Laboratory Tests Market, by End User

• 10.1. Introduction
• 10.2. Diagnostic Laboratories
• 10.3. Hospitals
• 10.4. Research Institutes

11. Americas Clinical Laboratory Tests Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Clinical Laboratory Tests Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Laboratory Tests Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Beckman Coulter receives FDA access to device designation for Alzheimer's Disease Blood Test
  • 14.3.2. Babson Diagnostics announced a strategic investment from BD to strengthen their partnership
  • 14.3.3. Labcorp announced an agreement with OPKO Health, Inc., to acquire select assets of BioReference Health
  • 14.3.4. BSI announced a strategic collaboration with Nelson Labs to enhance the supply chains
  • 14.3.5. Oncquest Laboratories Partners with Shruti Clinical Laboratory to Boost Advanced Testing Services in Mumbai
  • 14.3.6. Redcliffe Labs Acquires Medicentre, Strengthening Market Presence in Southern Rajasthan and Advancing Nationwide Growth
  • 14.3.7. Quest Diagnostics Enhances Maine Healthcare with Key Asset Acquisition from Northern Light Laboratory
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Accu Reference Medical Lab, LLC
• 3. Apollo Health and Lifestyle Limited
• 4. Arup Laboratories Inc.
• 5. Aster Clinical Lab LLP
• 6. Bioscientia Healthcare GmbH
• 7. Biosino Bio-technology and Science Inc.
• 8. Charles River Laboratories, Inc
• 9. Cinven Ltd.
• 10. Clinical Reference Laboratory, Inc.
• 11. DaVita Inc. by UnitedHealth Group Inc.
• 12. Dr Lal PathLabs Pvt. Ltd
• 13. Eurofins Scientific SE
• 14. Fresenius Medical Care AG & Co KGaA
• 15. Laboratory Corporation of America Holdings
• 16. Merck KgaA
• 17. Metropolis Health Products Retail Pvt Ltd.
• 18. NeoGenomics, Inc.
• 19. Novartis International AG
• 20. OPKO Health, Inc.
• 21. PerkinElmer, Inc.
• 22. Qiagen .N.V.
• 23. Quest Diagnostics Incorporated
• 24. Siemens Healthineers AG
• 25. Sonic Healthcare Limited
• 26. SYNLAB Group
• 27. Thermo Fisher Scientific Inc.